Lifyorli
Active substance: relacorilant
KIT · relacorilant
United StatesActive
Marketing holder: Corcept Therapeutics Incorporated
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-c39b-78b3-b102-c07f48e59414,01a12097-5da6-7494-ac35-e355fa8e297c,01a12097-5dab-72ca-b993-51ccb3bd4a18,01a1209c-311f-76a5-bfd9-054c59dbfa7d;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 76346-550
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 76346-550 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 76346-550 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 76346-550 · Verified 2026-10-09 · open in source